QSS
CTMX icon

Quantitative Systematic Strategies’s CytomX Therapeutics CTMX Stock Holding History

Quantitative Systematic Strategies’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,939
Closed -$165K – 456
2018
Q4 		$165K Buy
+10,939
New +$162K 0.04% 555
2016
Q1 		– Sell
-14,409
Closed -$300K – 494
2015
Q4 		$300K Buy
+14,409
New +$228K 0.08% 783

Other funds holding CTMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Quantitative Systematic Strategies's CTMX Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of CytomX Therapeutics (CTMX) in Q1 2019, closing a stake of 10,939 shares — an estimated $165K sold.

Quantitative Systematic Strategies first reported a position in CTMX in Q4 2015 and held it in 2 quarters. The position peaked at $300K in Q4 2015. 113 funds tracked by Wall St. Rank hold CTMX as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining CytomX Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 10,939 CytomX Therapeutics shares in Q1 2019, an estimated $165K.
  • Quantitative Systematic Strategies first reported a position in CytomX Therapeutics in Q4 2015 and held it in 2 quarters.
  • Quantitative Systematic Strategies's CytomX Therapeutics position peaked at $300K in Q4 2015.
  • 113 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.